Tecnologia e Inovação
Um sistema de inteligência artificial pode ajudar a prever infarto miocárdico por meio de escaneamento da retina e informações pessoais mínimas.
28 Jan, 2022 | 15:21hComunicado de imprensa: Using the eye as a window into heart disease – University of Leeds
Estudo original: Predicting myocardial infarction through retinal scans and minimal personal information – Nature Machine Intelligence (link para o resumo – $ para o texto completo)
Revisão | Inteligência artificial na saúde e na medicina.
25 Jan, 2022 | 11:45hAI in health and medicine – Nature Medicine (se o acesso a este link for pago, tente este)
Conteúdo relacionado: High-Performance Medicine: The Convergence of Human and Artificial Intelligence
Comentário no Twitter (fio – clique para saber mais)
🆕 Our review of #AI for medicine, just published @NatureMedicine https://t.co/OAoAGmErns@pranavrajpurkar, Emma Chen, Oishi Banerjee pic.twitter.com/oufp3nnOob
— Eric Topol (@EricTopol) January 20, 2022
Perspectiva | Prevenção do “overdiagnosis” digital.
25 Jan, 2022 | 11:43hPreventing Digital Overdiagnosis – JAMA (gratuito por período limitado)
Conteúdo relacionado: Overdiagnosis: it’s official – the term is now included in the medical subject headings (MeSH) vocabulary. (vários artigos sobre o tema)
Inteligência artificial para diagnóstico de graduação de Gleason do câncer de próstata: o desafio PANDA.
20 Jan, 2022 | 16:06hComentário: Large international evaluation shows AI accurately diagnoses prostate cancer – Karolinska Institutet
Comentário de um dos autores no Twitter (fio – clique para saber mais)
Honored to be part of the recently published study in Nature Medicine on the global #AI competition PANDA as a member of the @Google team and an expert panel of 6 US and Canadian Uropathologists. Check out this thread for my 5 top takeaways 👇#pathology #PathTwitter
— Dr. Mahul Amin (@DrMahul) January 14, 2022
O ano de 2021 na medicina cardiovascular: saúde digital e inovação.
13 Jan, 2022 | 20:55hThe year in cardiovascular medicine 2021: digital health and innovation – European Heart Journal
Com dados de dispositivos móveis (wearable data), um sistema de alerta em tempo real pode ser útil na detecção precoce de Covid-19 e outros eventos estressores.
1 Dez, 2021 | 15:41hReal-time alerting system for COVID-19 and other stress events using wearable data – Nature Medicine
Comentário: Scientists develop a smartwatch-based device for early detection of COVID-19 – News Medical
Comentário no Twitter
A study in @NatureMedicine shows that a smartwatch-based alerting system was able to detect pre-symptomatic and asymptomatic SARS-CoV-2 infection in a high percentage of cases. https://t.co/tquzpYa4pV pic.twitter.com/VIq3phKZ7J
— Nature Portfolio (@NaturePortfolio) November 30, 2021
193 países adotam o primeiro acordo global sobre Ética na Inteligência Artificial.
30 Nov, 2021 | 12:19hComunicado de imprensa: 193 countries adopt first-ever global agreement on the Ethics of Artificial Intelligence – United Nations
Ver Diretriz: Outcome document: first draft of the Recommendation on the Ethics of Artificial Intelligence – United Nations
Ponto de vista | O crescente fenômeno da atenção primária “virtual primeiro”.
24 Nov, 2021 | 11:27hThe Growing Phenomenon of “Virtual-First” Primary Care – JAMA (gratuito por tempo limitado)
Estudo randomizado | O uso de vídeos de realidade virtual para ensinar aos pacientes ambulatoriais sobre a preparação intestinal antes da colonoscopia melhorou a preparação em si, as taxas de detecção de pólipos e adenomas, bem como a confiança e a satisfação do paciente.
23 Nov, 2021 | 15:40h
Comentário no Twitter
RCT finds patients who received virtual reality video education before a colonoscopy had better bowel preparation, higher polyp and adenoma detection rates, and improved compliance and satisfaction. https://t.co/dAUtFf2m4B pic.twitter.com/RKAVZcVGuy
— JAMA Network Open (@JAMANetworkOpen) November 22, 2021
Nova terapia gênica para hemofilia A induz uma expressão sustentada de fatores de coagulação e reduziu os eventos hemorrágicos.
19 Nov, 2021 | 12:51hComunicado de imprensa: Novel gene therapy for hemophilia a leads to sustained expression of clotting factor and reduced bleeding events – Children’s Hospital of Philadelphia
Estudo original: Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A – New England Journal of Medicine
Comentário no Twitter
3.5 years after therapy with factor VIII-containing adeno-associated virus, 16 of 18 men with hemophilia A had enough factor VIII expression that bleeding events were reduced to nearly zero and prophylaxis was discontinued. https://t.co/n3cPyjGDkn pic.twitter.com/vPyz0OmT1S
— NEJM (@NEJM) November 18, 2021